Nuclear survivin was also significantly associated with early-stage ESCC (p = 0.039), which means ESCC patients with high level of nuclear survivin were more likely to be in the early-stage of disease (Table 2). The gene discussed is BIRC5; the disease is esophageal squamous cell carcinoma.